Edition:
United Kingdom

Biotest AG (BIOG_p.DE)

BIOG_p.DE on Xetra

22.00EUR
18 Apr 2019
Change (% chg)

€0.20 (+0.92%)
Prev Close
€21.80
Open
€21.95
Day's High
€22.10
Day's Low
€21.75
Volume
6,487
Avg. Vol
13,191
52-wk High
€26.75
52-wk Low
€19.82

Summary

Name Age Since Current Position

Rolf Hoffman

59 2017 Chairman of the Supervisory Board

Bernhard Ehmer

64 2015 Chairman of the Management Board

Cathrin Schleussner

2004 Deputy Chairperson of the Supervisory Board

Michael Ramroth

58 2004 Chief Financial Officer, Member of the Board of Management

Martin Moeller

Group Finance and Treasury Officer

Georg Floss

58 2013 Chief Operating Officer, Member of the Management Board

Juergen Kintzel

Information Technology Officer

Oliver Hein

Corporate Risk and Compliance Officer

Stephan Fleck

Corporate Controlling Officer

Enrico D'Aiuto

Global Sales Officer

Christina Erb

Human Resources Officer

Katrin Bernoester

Project Management Organization Officer

Josefine Buth

Corporate Regulatory Affairs Officer

Hermann Keuper

Manufacturing Operations Officer

Michael Moritz

Materials & Facility Management, Biotest Next Level Officer

Dirk Neumueller

Corporate Communication Officer

Martin Reinecke

Plasma Alliances and Protein Supply Officer

Joerg Schuettrumpf

Global Research Officer

Peter Seith

Quality Operations Officer

Frank Velte

Commercial Operations Germany Officer

Kerstin Birkhahn

2010 Member of the Supervisory Board, Employee Representative

Juergen Heilmann

2011 Member of the Supervisory Board, Employee Representative

Christine Kreidl

2017 Member of the Supervisory Board

Monika Buttkereit

Investor Relations Contact Officer

Biographies

Name Description

Rolf Hoffman

Dr. Rolf K. Hoffmann has been Chairman of the Supervisory Board at Biotest Aktiengesellschaft since August 30, 2017. He has been adjunct professor at University of North Carolina, Kenan-Flagler Business School, Chapel Hill, North Carolina. He is Chairman of the Personnel and Compensation Committee, Member of the Audit Committee and the Governance Committee at the Company.

Bernhard Ehmer

Dr. Bernhard R. M. Ehmer was Chairman of the Management Board of Biotest Aktiengesellschaft from January 1, 2015 until May 1, 2019. Previously, he served as Member of the Management Board of the Company from November 1, 2014. He got a Ph.D. in Medicine and was resident in internal medicine at a teaching hospital of the University of Heidelberg, before he started his career in the pharmaceutical industry first with Boehringer Mannheim, then with Merck KGaA. Later he was Chief Executive Officer of Fresenius Biotech GmbH before he joined Imclone Systems Corp. In his last position as Chief Executive Officer & President of Imclone Systems Corp. his focus has been in the clinical development and market preparation of biologic pharmaceuticals. Finally he integrated most of the key functions of Imclone Systems into the organization of Eli Lilly, the parent company of Imclone Systems.

Cathrin Schleussner

Dr. Cathrin Schleussner has been Deputy Chairperson of the Supervisory Board at Biotest Aktiengesellschaft since 2004. Previously, she was Member of the Company's Supervisory Board from July 2001. She serves as Managing Director at OGEL GmbH, Germany. She is a Biologist. She is Chairman of the Governance Committee at the Company.

Michael Ramroth

Dr. Michael Ramroth will be appointed as Chairman of the Management Board, Chief Executive Officer with effect from May 1, 2019. He has served as Chief Financial Officer and Member of the Board of Management of Biotest Aktiengesellschaft since 2004. From 1990 to 1997, he was head of the Business Development Department at Metallgesellschaft AG. From 1997 to 1999, he was on the Board of CeramTec AG, before he moved to MG Technologies AG as head of Finance (CFO) from 1999 to 2003. He obtained his Doctorate in Political Economy.

Martin Moeller

Georg Floss

Dr. Georg Floss has served as Chief Operating Officer and Member of the Management Board of Biotest Aktiengesellschaft since 2013. Previously, he was Executive Vice President of Plasma Protein Operations at the Company from 2008. Up until 1992, he worked in Production and Research & Development within the Veterinary Division of Bayer AG. From 1992 to 1999, he worked for Hoechst Roussel Veterinaer GmbH as a Production Manager, after which he became head of the Production Technical Management Department. From 1999 to 2005, he headed the Production Department of CSL Behring GmbH in Marburg, before taking on overall responsibility for production at the Marburg site in 2005. Dr. Floss earned a doctorate in virology after graduating in veterinary medicine.

Juergen Kintzel

Oliver Hein

Stephan Fleck

Enrico D'Aiuto

Christina Erb

Dr. Christina Erb is Human Resources Officer at Biotest Aktiengesellschaft. Prior to that, she was Vice President Project Management at the Company from August 2015. She joined Executive Management in 2013. She joined Biotest in 2009 and since she was responsible for the Project Management Organization and from 2012 onwards Head of the Intensive Medicine Center of Excellence. Before joining the Company, she spent six years with Merz Pharmaceuticals, where she worked for a number of years in central strategic marketing before she was responsible as project and later program manager for the strategic development of a globally marketed product to treat Alzheimer's disease. Following a research internship at the Hebrew University of Jerusalem in Israel, she worked as a laboratory Head in Preclinical Research pre-clinical central nervous system at Bayer AG from 2001 to 2003. She obtained doctorate in pharmacology after a degree in biology.

Katrin Bernoester

Josefine Buth

Hermann Keuper

Michael Moritz

Dirk Neumueller

Martin Reinecke

Dr. Martin Reinecke is Plasma Alliances and Protein Supply Officer at Biotest Aktiengesellschaft. His previous positions since his start at Biotest in 1997 were in Business Development and as Vice President of Strategic Alliances and Plasma Procurement. After conducting research at MIT in Cambridge, USA, from 1994 to 1996, he directed the office for patents and licensing for Universities in Lower Saxony, Germany. He is a chemist by education with a doctorate in chemical engineering at Universitaet Hannover.

Joerg Schuettrumpf

Dr. Joerg Schuettrumpf is Global Research Officer at Biotest Aktiengesellschaft. Previously, he was Director of the Haematology Research area at Biotest. From 2006 to 2012, he held various functions in transfusion medicine and research at the DRK (Deutsches Rotes Kreuz) blood donor service Baden-Wuerttemberg – Hessen, Germany. His previous positions were at Children's Hospital of Philadelphia and the University of Pennsylvania, where he worked in coagulation and gene therapy research from 2000 to 2005. He is a physician specialized in Transfusion Medicine and worked in clinical positions at the Essen and Frankfurt/Main University Hospitals, Germany, in the fields of hematology, coagulation and internal medicine.

Peter Seith

Frank Velte

Kerstin Birkhahn

Ms. Kerstin Birkhahn has been Member of the Supervisory Board and Employee Representative of Biotest Aktiengesellschaft since April 27, 2010. Previously, she served as Member of the Supervisory Board at the Company between September 24, 2009 and May 3, 2007. She is an Engineer. She is Member of the Personnel and Compensation Committee at the Company.

Juergen Heilmann

Mr. Juergen Heilmann has been Member of the Supervisory Board and Employee Representative of Biotest Aktiengesellschaft since September 22, 2011. He serves as an Administrative Staff Member. He is Member of the Audit Committee at the Company.

Christine Kreidl

Ms. Christine Kreidl has been Member of the Supervisory Board at Biotest Aktiengesellschaft since August 30, 2017. She is a Freelance Consultant. She is Vice Chairman of the Supervisory Board of Singulus Technologies AG. She is Chairman of the Audit Committee and Member of the Governance Committee at the Company.

Monika Buttkereit